US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anti-Pandemic Concept

1,379.06

+4.600.33%

Number of Gainers:9

Number of Losers:9

Number of Flat:1

PE:- -

High:1,392.07

Open:1,378.91

Low:1,377.90

Close:1,374.47

Loading ...

Johnson & Johnson Beats Sales Forecasts as Trump Renews Tariff Threats

J&J Raises Full-Year Outlook After Beating 2Q Expectations

BioNTech price target lowered to $126 from $127 at BofA

BioNTech SE (BNTX) Gets a Buy from Bank of America Securities

This Once-Dominant Healthcare Stock Down 50% Is Finally Ready for a Comeback

EQ Resources to Release Shares from Voluntary Escrow, Strengthening Tungsten Market Position

Director Jeffrey Bluestone Reports Disposal of Common Shares in Gilead Sciences Inc

Gilead Sciences Reaches $202 Million Settlement Over Kickback Scheme Promoting HIV Drugs

MT Newswires Live

BUZZ-PREVIEW: Johnson & Johnson shares lose ground ahead of quarterly results

Japan Discards 2.5M Doses of Expired Covid Drugs From Pfizer, Merck - Nikkei

THOMSON REUTERS

BRIEF-NY AG James- My Office And 48 AGS Secured $202 Million From Gilead Sciences - X Post

NY Ag James- My Office and 48 Ags Secured $202 Million From Gileadsciences - X Post

THOMSON REUTERS

MEDIA-Ex-Pfizer doctor tells Congress he didn’t delay covid shot data- Bloomberg News

Mizuho Securities Remains a Hold on Abbott Laboratories (ABT)

Co-Diagnostics Inc. to Showcase Innovations at WHX Kuala Lumpur

Abbott Labs Is Maintained at Equal-Weight by Morgan Stanley

Aethlon Medical Inc. Advances Hemopurifier Clinical Trial Following Positive Safety Review, Opens Enrollment for Next Patient Cohort

Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort

THOMSON REUTERS

Pfizer’s RSV Vaccine Trial: A Potential Game-Changer for Infants with HIV

Gilead Sciences and Arcus Biosciences: New Lung Cancer Treatment Combinations Under Evaluation

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4568/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1379.0648,"timestamp":1752868799999,"preClose":1374.4666,"halted":0,"volume":95962727,"delay":0,"changeRate":0.003345,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":4.598267,"latestTime":"07-18 16:00:00 EDT","open":1378.9058,"high":1392.0709,"low":1377.9001,"amount":6205677126.969449,"amplitude":0.01031,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753084800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.647019,"peRate":21.146563,"turnoverRate":0.006269,"increases":9,"decrements":9,"flats":1,"marketCap":1137445199268.5,"floatMarketCap":1116746960372.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1392.0709,"amplitude":0.01031,"preClose":1374.4666,"low":1377.9001,"pbRate":"3.647019","latestPrice":1379.0648,"volume":95962727,"delay":0,"open":1378.9058,"prevYearClose":1274.8187,"prevWeekClose":1397.679,"prevMonthClose":1377.5769,"prevQuarterClose":1377.5769,"fiveDayClose":1397.679,"twentyDayClose":1359.4229,"sixtyDayClose":1350.4775,"secType":"PLATE","market":"US","turnoverRate":0.006269,"peRate":21.146563,"marketCap":1137445199268.5,"floatMarketCap":1116746960372.5,"timestamp":1752868799999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":9,"down":9,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1197500433","title":"Johnson & Johnson Beats Sales Forecasts as Trump Renews Tariff Threats","url":"https://stock-news.laohu8.com/highlight/detail?id=1197500433","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197500433?lang=en_us&edition=fundamental","pubTime":"2025-07-16 18:30","pubTimestamp":1752661845,"startTime":"0","endTime":"0","summary":"Johnson & Johnson outperformed Wall Street expectations with its quarterly sales and raised its full-year outlook, signaling corporate resilience amid dual threats of tariffs and drug pricing...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930813.SGD","LU1732799900.SGD","IE00BBT3K403.USD","LU0234570918.USD","LU0912757837.SGD","BK4504","LU0889566641.SGD","LU1162221912.USD","IE00B4R5TH58.HKD","LU1032466523.USD","BK4532","LU1221951046.USD","LU1674673428.USD","IE0002270589.USD","LU1066051811.HKD","LU0098860793.USD","LU1914381329.SGD","BK4588","IE00BLSP4239.USD","IE00B19Z3B42.SGD","LU1023059063.AUD","LU2133065610.SGD","IE000M9KFDE8.USD","IE00B2B36J28.USD","LU1074936037.SGD","BK4581","BK4534","LU2347655156.SGD","SG9999001440.SGD","IE00BGHQF631.EUR","LU2592432038.USD","IE0034235303.USD","LU1261432733.SGD","LU0345769631.USD","LU1732800096.USD","LU0203345920.USD","LU1244550494.USD","LU2089984988.USD","LU1244550221.USD","LU0345770308.USD","LU1066051498.USD","LU1506573853.SGD","IE00B7SZLL34.SGD","IE00BJT1NW94.SGD","IE0002141913.USD","IE00BFXG1179.USD","BK4007","LU0114720955.EUR","LU2129689514.USD","LU2430703251.USD","BK4550","LU1894683264.USD","IE00B1BXHZ80.USD","LU1059921491.USD","LU0203347892.USD","LU1430594728.SGD","LU2129689605.HKD","LU2505996509.AUD","SG9999002224.SGD","IE00B3PB1722.GBP","LU1674673691.USD","LU1585245621.USD","LU2430703095.HKD","LU2112291526.USD","IE00B3T34201.USD","IE00BDGV0183.EUR","LU0466842654.USD","LU1221951129.SGD","BK4568","LU0289739699.SGD","LU1935042991.SGD","IE00B19Z3581.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","BK4592","LU1066053197.SGD","LU2129689431.USD","IE00BN8TJ469.HKD","LU0320765646.SGD","LU2468319806.SGD","LU1196500208.SGD","LU2505996681.GBP","IE00B42XCP33.USD","LU1032955483.USD","LU1244550577.SGD","LU0058720904.USD","LU1057294990.SGD","JNJ","LU1280957306.USD","IE00BLSP4452.SGD","LU0345769128.USD","LU2602419157.SGD","LU0234572021.USD","BK4533","LU0345770993.USD","LU2430703178.SGD","LU1778281490.HKD","LU0640476718.USD","LU0792757196.USD","IE00BVYPNV92.GBP","IE00BVYPNW00.USD","LU1718418525.SGD","LU0795875169.SGD","LU0122379950.USD","LU1894683348.USD","LU0795875086.SGD","LU1929549753.HKD","BK4559","LU0985320562.USD","LU1066051225.USD","IE00BFTCPJ56.SGD","BK4585","LU1061106388.HKD","SG9999002232.USD","LU0882574055.USD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2551714288","title":"J&J Raises Full-Year Outlook After Beating 2Q Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2551714288","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551714288?lang=en_us&edition=fundamental","pubTime":"2025-07-16 18:20","pubTimestamp":1752661200,"startTime":"0","endTime":"0","summary":"Johnson & Johnson boosted its full-year outlook as it posted better-than-expected profit and sales in the second quarter.The healthcare-products company said Tuesday it now expects adjusted per-share earnings of $10.80 to $10.90, up from its previous range of $10.50 to $10.70. Analysts polled by FactSet expect $10.64.The company also raised its sales outlook for the year to a range of $93.2 billion to $93.6 billion, compared with its prior view of $91 billion to $91.8 billion. Analysts surveyed by FactSet forecast sales of $91.42 billion for the year.Chief Executive Joaquin Duato said the company is positioned for elevated growth in the second half of the year with approvals and submissions anticipated in areas including lung and bladder cancer, depression and psoriasis.The forecast also reflects favorable foreign-exchange effects, the company said.The updated outlook came as J&J posted a profit of $5.54 billion, or $2.29 a share, in the second quarter, compared with a profit of $4.69 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2112291526.USD","IE00BGHQF631.EUR","IE00BVYPNV92.GBP","LU2129689514.USD","LU0320765646.SGD","LU1914381329.SGD","BK4533","LU2430703178.SGD","IE00BSNM7G36.USD","SG9999002232.USD","LU0289739699.SGD","LU0889566641.SGD","LU0912757837.SGD","LU0234572021.USD","SG9999002224.SGD","LU1162221912.USD","LU2129689431.USD","BK4534","BK4588","IE00BJJMRZ35.SGD","IE00B3T34201.USD","SG9999001440.SGD","LU1732799900.SGD","LU0203345920.USD","BK4550","LU1778281490.HKD","LU1894683348.USD","LU1244550577.SGD","IE00BJT1NW94.SGD","IE00B7SZLL34.SGD","LU1032955483.USD","IE00B1BXHZ80.USD","LU2430703095.HKD","IE00BBT3K403.USD","IE00B2B36J28.USD","LU2468319806.SGD","LU0345770308.USD","BK4585","IE00B42XCP33.USD","LU1221951046.USD","LU1066053197.SGD","LU1894683264.USD","LU0795875086.SGD","BK4592","LU0882574055.USD","BK4559","BK4568","LU1929549753.HKD","LU1267930813.SGD","JNJ"],"gpt_icon":0},{"id":"2551144395","title":"BioNTech price target lowered to $126 from $127 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2551144395","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551144395?lang=en_us&edition=fundamental","pubTime":"2025-07-16 17:55","pubTimestamp":1752659742,"startTime":"0","endTime":"0","summary":"BofA lowered the firm’s price target on BioNTech (BNTX) to $126 from $127 and keeps a Buy rating on the shares. BofA remains cautious on the near-t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biontech-price-target-lowered-to-126-from-127-at-bofa-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biontech-price-target-lowered-to-126-from-127-at-bofa-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4548","BK4139","BK4585","BK4551","BK4588","BK4535","BK4568","BNTX"],"gpt_icon":0},{"id":"2551144568","title":"BioNTech SE (BNTX) Gets a Buy from Bank of America Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2551144568","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551144568?lang=en_us&edition=fundamental","pubTime":"2025-07-16 17:46","pubTimestamp":1752659202,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Tazeen Ahmad reiterated a Buy rating on BioNTech SE yesterday and set a price target of $126.00. The company’s s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/biontech-se-bntx-gets-a-buy-from-bank-of-america-securities-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/biontech-se-bntx-gets-a-buy-from-bank-of-america-securities-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1280957306.USD","IE00B7SZLL34.SGD","LU0314106906.USD","LU2133065610.SGD","BK4535","LU0648001328.SGD","LU2129689514.USD","LU0971096721.USD","LU0320765489.SGD","LU0477156797.USD","LU0980610538.SGD","LU0477156953.USD","LU1718418525.SGD","BK4585","LU2129689605.HKD","IE00BKVL7J92.USD","LU1506573853.SGD","LU0256863811.USD","LU0149725797.USD","LU1496350171.SGD","LU0306807586.USD","LU0070302665.USD","BK4568","LU0098860793.USD","LU0648000940.SGD","BK4588","IE00BLSP4239.USD","LU0130517989.USD","LU0234572021.USD","LU1894683264.USD","IE00BFXG1179.USD","LU0306806265.USD","LU1201861249.SGD","LU1880398554.USD","LU1363072403.SGD","LU0321505868.SGD","BK4548","LU0417517546.SGD","LU1162221912.USD","LU1668664300.SGD","BAC","LU0053666078.USD","BNTX","BK4559","LU0320765646.SGD","IE00B19Z3B42.SGD","LU0130102774.USD","IE00BBT3K403.USD","IE00B1BXHZ80.USD","LU1791807156.HKD"],"gpt_icon":0},{"id":"2551145447","title":"This Once-Dominant Healthcare Stock Down 50% Is Finally Ready for a Comeback","url":"https://stock-news.laohu8.com/highlight/detail?id=2551145447","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551145447?lang=en_us&edition=fundamental","pubTime":"2025-07-16 16:12","pubTimestamp":1752653520,"startTime":"0","endTime":"0","summary":"Pfizer’s earnings and stock price soared in early pandemic days thanks to its coronavirus treatment and vaccine.But waning demand for those products has put the company under pressure in recent years.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/07/16/this-once-dominant-healthcare-stock-down-__-is-fin/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0122379950.USD","HCSG","BK4599","SG9999001176.USD","SG9999013999.USD","IE00BLSP4452.SGD","BK4592","LU0321505868.SGD","LU0321505439.SGD","BK4550","LU1066053197.SGD","BK4585","LU0234572021.USD","PFE","BK4533","LU1883839398.USD","SG9999011175.SGD","LU0058720904.USD","LU0306806265.USD","LU0456855351.SGD","LU0289739699.SGD","SGXZ57979304.SGD","SG9999002224.SGD","BK4534","SG9999001176.SGD","LU0170899867.USD","IE00B19Z3B42.SGD","LU0985481810.HKD","LU1023059063.AUD","LU1894683348.USD","SG9999003800.SGD","IE00B19Z3581.USD","LU0868494617.USD","IE00BBT3K403.USD","LU1057294990.SGD","LU0225771236.USD","LU0306807586.USD","SG9999002232.USD","IE00BLSP4239.USD","BK4007","BK4588","IE000M9KFDE8.USD","BK4137","BK4568","BK4581","IE0002270589.USD","LU0225284248.USD","LU1894683264.USD","LU1066051498.USD"],"gpt_icon":0},{"id":"2551190256","title":"EQ Resources to Release Shares from Voluntary Escrow, Strengthening Tungsten Market Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2551190256","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551190256?lang=en_us&edition=fundamental","pubTime":"2025-07-16 07:57","pubTimestamp":1752623869,"startTime":"0","endTime":"0","summary":"EQ Resources Limited ( ($AU:EQR) ) has shared an update. EQ Resources Limited announced the release of 127,323,657 fully paid ordinary shares from ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eq-resources-to-release-shares-from-voluntary-escrow-strengthening-tungsten-market-position?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eq-resources-to-release-shares-from-voluntary-escrow-strengthening-tungsten-market-position?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","BK4139","EQ"],"gpt_icon":0},{"id":"2551194413","title":"Director Jeffrey Bluestone Reports Disposal of Common Shares in Gilead Sciences Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2551194413","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551194413?lang=en_us&edition=fundamental","pubTime":"2025-07-16 03:59","pubTimestamp":1752609597,"startTime":"0","endTime":"0","summary":"Jeffrey Bluestone, a Director at Gilead Sciences Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 15, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250715:nNDL6zSKpL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0823416689.USD","LU0889565916.HKD","BK4578","IE00BSNM7G36.USD","LU0289739699.SGD","BK4550","LU1066053197.SGD","LU1430594728.SGD","LU1674673428.USD","LU2087621335.USD","LU0109394709.USD","IE00BKVL7J92.USD","SG9999015978.USD","LU0234570918.USD","GILD","LU0320765992.SGD","SG9999015986.USD","LU1778281490.HKD","LU1585245621.USD","IE00B7SZLL34.SGD","LU2089984988.USD","LU1571399168.USD","IE0002270589.USD","BK4588","IE00B19Z3B42.SGD","LU0058720904.USD","BK4139","LU1674673691.USD","LU1839511570.USD","IE00BZ1G4Q59.USD","BK4566","LU2324357040.USD","BK4583","BK4568","BK4532","IE00B3T34201.USD","LU2468319806.SGD","SG9999015952.SGD","SG9999015945.SGD","LU1066051498.USD","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2551194848","title":"Gilead Sciences Reaches $202 Million Settlement Over Kickback Scheme Promoting HIV Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2551194848","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551194848?lang=en_us&edition=fundamental","pubTime":"2025-07-16 03:04","pubTimestamp":1752606251,"startTime":"0","endTime":"0","summary":"Gilead Sciences (GILD) has agreed to pay $202 million to settle claims that it violated US anti-kickback laws through its HIV drug speaker programs, according to a Tuesday statement by New York Attorn","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B3T34201.USD","BK4578","LU0234570918.USD","LU1585245621.USD","SG9999015978.USD","LU1778281490.HKD","BK4583","LU1674673691.USD","LU0320765992.SGD","IE00B19Z3581.USD","IE00B7SZLL34.SGD","LU0889565916.HKD","BK4532","BK4585","GILD","LU2089984988.USD","LU2468319806.SGD","LU1430594728.SGD","LU2324357040.USD","LU1839511570.USD","SG9999015945.SGD","LU0058720904.USD","IE0002270589.USD","BK4566","IE00BSNM7G36.USD","LU1571399168.USD","LU1674673428.USD","LU1066051498.USD","SG9999015986.USD","BK4568","IE00BZ1G4Q59.USD","LU0289739699.SGD","BK4139","SG9999015952.SGD","IE00BKVL7J92.USD","BK4588","LU1066053197.SGD","BK4550","LU2087621335.USD","LU0823416689.USD","IE00B19Z3B42.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"2551191946","title":"BUZZ-PREVIEW: Johnson & Johnson shares lose ground ahead of quarterly results","url":"https://stock-news.laohu8.com/highlight/detail?id=2551191946","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551191946?lang=en_us&edition=fundamental","pubTime":"2025-07-16 02:28","pubTimestamp":1752604129,"startTime":"0","endTime":"0","summary":"BUZZ-PREVIEW: Johnson & Johnson shares lose ground ahead of quarterly results** Johnson & Johnson's JNJ.N shares are down ~1% to $155.45 on Tues ahead of the pharma co's quarterly earnings due on Wed,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250715:nL6N3TC0S2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","LU0985320562.USD","LU2505996681.GBP","LU2468319806.SGD","IE00B42XCP33.USD","SG9999002232.USD","IE00BFTCPJ56.SGD","LU2112291526.USD","IE00BLSP4239.USD","LU1261432733.SGD","IE00BSNM7G36.USD","LU2129689431.USD","IE0002141913.USD","IE00BLSP4452.SGD","LU0122379950.USD","LU0795875086.SGD","LU1059921491.USD","LU1778281490.HKD","BK4585","LU0058720904.USD","LU1196500208.SGD","LU1023059063.AUD","LU1267930813.SGD","LU0882574055.USD","LU0234572021.USD","LU1066051811.HKD","IE00BDGV0183.EUR","LU1894683264.USD","LU0345770308.USD","LU1032955483.USD","LU2602419157.SGD","BK4559","LU0289739699.SGD","LU0466842654.USD","LU0203347892.USD","BK4568","IE00B4R5TH58.HKD","LU1732799900.SGD","BK4588","IE00BN8TJ469.HKD","LU1221951046.USD","IE00B19Z3B42.SGD","JNJ","LU0234570918.USD","LU1244550221.USD","LU2347655156.SGD","IE00BFXG1179.USD","LU0345769631.USD","LU0640476718.USD","LU1244550577.SGD"],"gpt_icon":0},{"id":"2551191593","title":"Japan Discards 2.5M Doses of Expired Covid Drugs From Pfizer, Merck - Nikkei","url":"https://stock-news.laohu8.com/highlight/detail?id=2551191593","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551191593?lang=en_us&edition=fundamental","pubTime":"2025-07-16 02:15","pubTimestamp":1752603308,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250715:nFWN3TC0GL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0122379950.USD","LU1093756168.USD","BK4599","SG9999001176.USD","LU2112291526.USD","BK4592","IE00B4R5TH58.HKD","LU0320765646.SGD","LU0321505868.SGD","LU1116320901.HKD","IE00B2B36J28.USD","BK4585","LU1093756325.SGD","LU0234572021.USD","PFE","BK4533","LU0208291251.USD","LU0058720904.USD","LU0306806265.USD","SG9999011175.SGD","LU1585245621.USD","LU1974910355.USD","LU1066051225.USD","IE00B19Z3B42.SGD","LU0985481810.HKD","LU1023059063.AUD","LU1894683348.USD","SG9999003800.SGD","IE0009355771.USD","LU0868494617.USD","LU1291159041.SGD","LU1571399168.USD","IE00BBT3K403.USD","SG9999001440.SGD","IE00BJJMRZ35.SGD","SG9999014567.USD","IE00BLSP4239.USD","LU0965508806.USD","BK4007","LU1037948541.HKD","LU1894683264.USD","IE0002141913.USD","MRK","BK4568","BK4581","LU0225284248.USD","LU0965509101.SGD","LU2361045086.USD","LU0106261372.USD","LU1066051498.USD"],"gpt_icon":0},{"id":"2551196293","title":"BRIEF-NY AG James- My Office And 48 AGS Secured $202 Million From Gilead Sciences - X Post","url":"https://stock-news.laohu8.com/highlight/detail?id=2551196293","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551196293?lang=en_us&edition=fundamental","pubTime":"2025-07-16 00:30","pubTimestamp":1752597003,"startTime":"0","endTime":"0","summary":"BRIEF-NY AG James- My Office And 48 AGS Secured $202 Million From Gilead Sciences - X PostJuly 15 (Reuters) - Gilead Sciences Inc GILD.O:NY AG JAMES- MY OFFICE AND 48 AGS SECURED $202 MILLION FROM GILEADSCIENCES - X POSTSource https://tinyurl.com/ymr5t6ca ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250715:nFWN3TC13A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","IE00B19Z3581.USD","LU0823416689.USD","BK4550","LU2468319806.SGD","IE00B19Z3B42.SGD","LU1571399168.USD","BK4578","LU1778281490.HKD","IE00B7SZLL34.SGD","LU0320765992.SGD","SG9999015945.SGD","BK4139","BK4568","LU1585245621.USD","LU2324357040.USD","SG9999015978.USD","BK4532","SG9999015952.SGD","IE00B3T34201.USD","LU0058720904.USD","LU0289739699.SGD","LU1674673691.USD","LU0889565916.HKD","LU1674673428.USD","BK4585","LU0109394709.USD","LU1066051498.USD","BK4583","GILD","LU1430594728.SGD","LU1066053197.SGD","LU1839511570.USD","IE00BKVL7J92.USD","LU2089984988.USD","IE00BZ1G4Q59.USD","SG9999015986.USD","LU0234570918.USD","IE0002270589.USD","IE00BSNM7G36.USD","LU2087621335.USD","BK4588"],"gpt_icon":0},{"id":"2551196281","title":"NY Ag James- My Office and 48 Ags Secured $202 Million From Gileadsciences - X Post","url":"https://stock-news.laohu8.com/highlight/detail?id=2551196281","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551196281?lang=en_us&edition=fundamental","pubTime":"2025-07-16 00:30","pubTimestamp":1752597002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250715:nFWN3TC13A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1066053197.SGD","IE00BSNM7G36.USD","IE00B19Z3581.USD","IE00B3T34201.USD","LU1430594728.SGD","LU1571399168.USD","SG9999015986.USD","LU0320765992.SGD","SG9999015945.SGD","LU2089984988.USD","LU1066051498.USD","IE00BZ1G4Q59.USD","LU2468319806.SGD","BK4566","LU1778281490.HKD","LU0234570918.USD","LU0823416689.USD","BK4532","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","BK4550","SG9999015978.USD","BK4578","SG9999015952.SGD","LU0889565916.HKD","LU1674673691.USD","BK4583","LU2087621335.USD","LU0289739699.SGD","BK4585","LU0058720904.USD","GILD","LU1674673428.USD","BK4139","IE0002270589.USD","BK4568","BK4588","IE00B7SZLL34.SGD","LU1839511570.USD","LU0109394709.USD","LU1585245621.USD","LU2324357040.USD"],"gpt_icon":0},{"id":"2551519301","title":"MEDIA-Ex-Pfizer doctor tells Congress he didn’t delay covid shot data- Bloomberg News","url":"https://stock-news.laohu8.com/highlight/detail?id=2551519301","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551519301?lang=en_us&edition=fundamental","pubTime":"2025-07-15 23:05","pubTimestamp":1752591922,"startTime":"0","endTime":"0","summary":"MEDIA-Ex-Pfizer doctor tells Congress he didn’t delay covid shot data- Bloomberg News -- Source link: https://tinyurl.com/4ptapmws-- Note: Reuters has not verified this story and does not vouch for its accuracy ((Bengaluru newsroom, globalnewsmonitoring@thomsonreuters.com))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250715:nL4N3TC1GG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001176.USD","BK4534","LU1066051498.USD","BK4588","LU0321505868.SGD","IE00B19Z3B42.SGD","BK4568","IE000M9KFDE8.USD","LU0868494617.USD","LU0306806265.USD","LU0225284248.USD","LU1023059063.AUD","BK4550","LU0321505439.SGD","IE00BLSP4239.USD","IE00B19Z3581.USD","LU1057294990.SGD","BK4007","BK4581","LU0456855351.SGD","IE00BBT3K403.USD","LU0058720904.USD","LU0170899867.USD","LU1883839398.USD","BK4599","BK4585","IE0002270589.USD","LU1894683348.USD","BK4592","SG9999002224.SGD","LU0289739699.SGD","LU0306807586.USD","PFE","SG9999001176.SGD","SG9999011175.SGD","SG9999003800.SGD","BK4533","SGXZ57979304.SGD","LU0225771236.USD","LU1066053197.SGD","LU0234572021.USD","LU1894683264.USD","SG9999002232.USD","LU0122379950.USD","SG9999013999.USD","LU0985481810.HKD","IE00BLSP4452.SGD"],"gpt_icon":0},{"id":"2551631193","title":"Mizuho Securities Remains a Hold on Abbott Laboratories (ABT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2551631193","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551631193?lang=en_us&edition=fundamental","pubTime":"2025-07-15 22:35","pubTimestamp":1752590122,"startTime":"0","endTime":"0","summary":"In a report released today, Anthony Petrone from Mizuho Securities maintained a Hold rating on Abbott Laboratories, with a price target of $140.00....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mizuho-securities-remains-a-hold-on-abbott-laboratories-abt-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mizuho-securities-remains-a-hold-on-abbott-laboratories-abt-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4504","LU1061106388.HKD","LU2089984988.USD","BK4581","SGXZ23171101.USD","IE00BFTCPJ56.SGD","BK4588","MFG","IE00B2B36J28.USD","SG9999002232.USD","LU2133065610.SGD","IE00BJJMRZ35.SGD","LU0122379950.USD","LU1057294990.SGD","IE0002141913.USD","LU1023059063.AUD","IE00BJT1NW94.SGD","BK4566","LU2468319806.SGD","SG9999004303.SGD","ABT","LU0234572021.USD","SG9999002224.SGD","LU2112291526.USD","BK4568","BK4585","LU2237957902.USD","LU0868494617.USD","LU1989763427.SGD","BK4207","BK4592","LU0170899867.USD","BK4533","IE0009355771.USD","LU1989763690.USD","LU1721429402.USD","LU2237957811.SGD","LU1721429741.USD","LU0266013472.USD","LU1914381329.SGD","LU1691799644.USD","BK4082","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2551606251","title":"Co-Diagnostics Inc. to Showcase Innovations at WHX Kuala Lumpur","url":"https://stock-news.laohu8.com/highlight/detail?id=2551606251","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551606251?lang=en_us&edition=fundamental","pubTime":"2025-07-15 21:30","pubTimestamp":1752586228,"startTime":"0","endTime":"0","summary":"Co-Diagnostics, Inc., a molecular diagnostics company, will host a booth at WHX Kuala Lumpur from July 16-18, 2025, at the Malaysia International Trade and Exhibition Centre. The company plans to increase interest in its suite of PCR in vitro diagnostics for infectious diseases, promote its Co-Primers technology, and introduce its upcoming Co-Dx PCR platform, including the Co-Dx PCR MTB test and the 8-plex Co-Dx HPV test.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via PR Newswire  on July 15, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250715:nNDL3MxNZy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","CODX","BK4082"],"gpt_icon":0},{"id":"2551605031","title":"Abbott Labs Is Maintained at Equal-Weight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2551605031","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551605031?lang=en_us&edition=fundamental","pubTime":"2025-07-15 21:13","pubTimestamp":1752585180,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ABT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 15, 2025 09:13 ET (13:13 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","LU2133065610.SGD","LU2237957811.SGD","LU0170899867.USD","IE00BZ1G4Q59.USD","LU1074936037.SGD","LU0795875169.SGD","LU0158827781.USD","LU2023251221.USD","LU1914381329.SGD","BK4516","LU1989763690.USD","LU0320765646.SGD","LU2089283258.USD","LU0912757837.SGD","LU2111349929.HKD","LU2089284900.SGD","LU1057294990.SGD","SG9999002232.USD","LU1721429402.USD","LU0267386448.USD","BK4588","LU1732800096.USD","BK4534","IE00BJJMRZ35.SGD","LU2237957902.USD","BK4533","LU0225283273.USD","LU0868494617.USD","LU0006306889.USD","LU2112291526.USD","IE00B2B36J28.USD","LU2271345857.HKD","LU1548497426.USD","ABT","BK4504","LU0106831901.USD","LU0795875086.SGD","LU1720051017.SGD","BK4568","LU1989763427.SGD","SGXZ23171101.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","LU1989772840.SGD","LU0234572021.USD","LU1691799644.USD","SG9999002224.SGD","IE0009355771.USD","BK4127"],"gpt_icon":0},{"id":"2551162393","title":"Aethlon Medical Inc. Advances Hemopurifier Clinical Trial Following Positive Safety Review, Opens Enrollment for Next Patient Cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2551162393","media":"Reuters","labels":["executive","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551162393?lang=en_us&edition=fundamental","pubTime":"2025-07-15 20:03","pubTimestamp":1752581031,"startTime":"0","endTime":"0","summary":"Aethlon Medical Inc. Advances Hemopurifier Clinical Trial Following Positive Safety Review, Opens Enrollment for Next Patient Cohort. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aethlon Medical Inc. published the original content used to generate this news brief via PR Newswire  on July 15, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250715:nNDL6STSr1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","AEMD","BK4583","BK4082"],"gpt_icon":0},{"id":"2551164457","title":"Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2551164457","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551164457?lang=en_us&edition=fundamental","pubTime":"2025-07-15 20:01","pubTimestamp":1752580863,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250715:nTUA5XLBWM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AEMD","BK4568","BK4082","BK4583"],"gpt_icon":0},{"id":"2551180416","title":"Pfizer’s RSV Vaccine Trial: A Potential Game-Changer for Infants with HIV","url":"https://stock-news.laohu8.com/highlight/detail?id=2551180416","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551180416?lang=en_us&edition=fundamental","pubTime":"2025-07-15 00:06","pubTimestamp":1752509193,"startTime":"0","endTime":"0","summary":"Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Study Overview: Pfizer Inc. is conducting a Phase 3 clinical trial titled ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pfizers-rsv-vaccine-trial-a-potential-game-changer-for-infants-with-hiv?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pfizers-rsv-vaccine-trial-a-potential-game-changer-for-infants-with-hiv?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999001176.USD","BK4534","LU1066051498.USD","BK4588","LU0321505868.SGD","IE00B19Z3B42.SGD","BK4568","IE000M9KFDE8.USD","LU0868494617.USD","LU0306806265.USD","LU0225284248.USD","LU1023059063.AUD","BK4550","LU0321505439.SGD","IE00BLSP4239.USD","IE00B19Z3581.USD","LU1057294990.SGD","BK4007","BK4581","LU0456855351.SGD","IE00BBT3K403.USD","LU0058720904.USD","LU0170899867.USD","LU1883839398.USD","BK4599","BK4585","IE0002270589.USD","LU1894683348.USD","BK4592","SG9999002224.SGD","LU0289739699.SGD","LU0306807586.USD","PFE","SG9999001176.SGD","SG9999011175.SGD","SG9999003800.SGD","BK4533","SGXZ57979304.SGD","LU0225771236.USD","LU1066053197.SGD","LU0234572021.USD","LU1894683264.USD","SG9999002232.USD","LU0122379950.USD","SG9999013999.USD","LU0985481810.HKD","IE00BLSP4452.SGD"],"gpt_icon":0},{"id":"2551180988","title":"Gilead Sciences and Arcus Biosciences: New Lung Cancer Treatment Combinations Under Evaluation","url":"https://stock-news.laohu8.com/highlight/detail?id=2551180988","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551180988?lang=en_us&edition=fundamental","pubTime":"2025-07-15 00:01","pubTimestamp":1752508913,"startTime":"0","endTime":"0","summary":"Gilead Sciences (($GILD)), Arcus Biosciences (($RCUS)), Gilead Sciences (($CC:GILD.CUR)) announced an update on their ongoing clinical study. The V...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gilead-sciences-and-arcus-biosciences-new-lung-cancer-treatment-combinations-under-evaluation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gilead-sciences-and-arcus-biosciences-new-lung-cancer-treatment-combinations-under-evaluation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z3581.USD","BK4578","IE00BSNM7G36.USD","LU2089984988.USD","LU0289739699.SGD","LU1571399168.USD","LU2324357040.USD","SG9999015978.USD","SG9999015945.SGD","BK4139","BK4588","SG9999015952.SGD","LU1430594728.SGD","IE00B3T34201.USD","LU1585245621.USD","LU0320765992.SGD","LU1674673691.USD","BK4550","LU0823416689.USD","LU1066051498.USD","LU0889565916.HKD","LU1778281490.HKD","LU2087621335.USD","SG9999015986.USD","GILD","IE00BKVL7J92.USD","IE00B7SZLL34.SGD","LU0234570918.USD","BK4566","LU1674673428.USD","BK4583","LU2468319806.SGD","LU0058720904.USD","LU0109394709.USD","BK4585","IE00BZ1G4Q59.USD","LU1066053197.SGD","LU1839511570.USD","BK4532","BK4568","IE0002270589.USD","IE00B19Z3B42.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":5,"totalSize":237,"code":"91000000","status":"200"}]}}